Home

Insights

Hester Biosciences Ltd dividend

Hester Biosciences Ltd dividend

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.2 K

stocks traded

Image

Hester Biosciences Ltd

NSE: HESTERBIO

DPS

8

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Hester Biosciences Ltd is ₹ 8 as of 2023 .a1#The Dividend Payout of Hester Biosciences Ltd changed from 21.35 % on March 2019 to 21.05 % on March 2023 . This represents a CAGR of -0.28% over 5 years. a1#The Latest Trading Price of Hester Biosciences Ltd is ₹ 1786 as of 24 May 15:30 .a1#The Market Cap of Hester Biosciences Ltd changed from ₹ 1314 crore on March 2019 to ₹ 1293 crore on March 2023 . This represents a CAGR of -0.32% over 5 years. a1#The Revenue of Hester Biosciences Ltd changed from ₹ 55.39 crore to ₹ 83.88 crore over 8 quarters. This represents a CAGR of 23.06% a1#The EBITDA of Hester Biosciences Ltd changed from ₹ 12.12 crore to ₹ 20.55 crore over 8 quarters. This represents a CAGR of 30.21% a1#The Net Profit of Hester Biosciences Ltd changed from ₹ 3.56 crore to ₹ 6.4 crore over 8 quarters. This represents a CAGR of 34.08% a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

Share Price Vs Dividend Yield

swot
swot

Fundamental Metrics

Market Cap

1,520 Cr

EPS

22.2

P/E Ratio (TTM) *

80.5

P/B Ratio (TTM) *

5.2

DTE *

0.8

ROE *

6.5

ROCE *

8.7

Dividend Yield *

0.53

DPS *

8

Dividend Payout *

21.05

Ann.Dividend % *

80

* All values are consolidated

* All values are consolidated

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1921
Mar '2018
Mar '2121
Mar '2222
Mar '2321

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Hester Biosciences Ltd

NSE: HESTERBIO

PRICE

1786

10.60(0.60%)

stock direction

Last updated : 24 May 15:30

SWOT Analysis Of Hester Biosciences Ltd

Strength

1

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

Dividend Overview for Hester Biosciences Ltd

  • Hester Biosciences Ltd, boasts of a market capitalization of Rs 1521 Cr., with a share price of Rs 1786.00 as of 24 May 15:30. While all stocks don't consistently pay dividends, Hester Biosciences Ltd rewarded its shareholders, distributing 21.0 % for the full year.
  • In the year ending 2022, Hester Biosciences Ltd declared a dividend of Rs 10, resulting in a dividend yield of 0.4% Assessing its dividend-paying capacity and valuation is crucial to determine its suitability as a dividend stock.
  • During the year ending 2023, Hester Biosciences Ltd recorded revenues of Rs 305 Cr, with a trailing EBITDA Margin of 22.6% and net-profit of Rs 19 Cr

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '191315
Mar '20787
Mar '211631
Mar '222310
Mar '231293

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '2255
Sep '2278
Dec '2281
Mar '2271
Jun '2390
Sep '2376
Dec '2369
Mar '2384

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '2212
Sep '2218
Dec '2225
Mar '2215
Jun '2317
Sep '2319
Dec '2312
Mar '2321

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '224
Sep '227
Dec '2212
Mar '226
Jun '237
Sep '234
Dec '234
Mar '236

* All values are a in crore

About Hester Biosciences Ltd

About Hester Biosciences Ltd

    Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India. Since its incorporation in Apr' 87, the Company has been engaged in the production and distribution of vaccines and health products. Headquartered in Ahmedabad, Gujarat, the Company is currently the second-largest maker of poultry vaccines in India, having acquired strong brand equity over the years. The Company principally engages in two business verticals, namely Poultry Healthcare and Animal Healthcare. Its products are registered with several countries, and internal agencies, and have gained widespread recognition in both India and international markets. It has built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh. The products and services offered include over 51 vaccines and 70+ health products. In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals. The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company received licenses for producing 10 additional poultry vaccines. It signed a manufacturing agreement with Sinsui Inc for producing poultry vaccines. In 2003, Hester was appointed as the exclusive Indian distributor by BIOPHARM of Czech Republic, for their coccidiosis vaccine - LIVACOX. Hester commenced business with Merial in the 3rd quarter of the financial year by importing poultry vaccines from them in 2004-05 and therefore, name of Company was changed from HESTER PHARMACEUTICALS LIMITED to HESTER BIOSCIENCES LIMITED. The Company embarked on an expansion program, to increase its capacity from 1200 million doses to 4800 million doses, which was commenced in January 2006. The expansion project and the new expanded capacity went on-stream in March 2007. The distribution network within India was made functional with company managed depots at Pune, Bangalore, Coimbatore, Hyderabad and Chandigarh, having state-of-art cold store facilities to maintain the cold chain. Distribution costs were further cut by embarking on the use of company owned refrigerated vans for deliveries all across India. In January 2010, the company re-launched the freeze dried MD Vaccine after 5 years. A JV was set-up in Nepal to facilitate manufacture of specific animal vaccines for international markets in 2011 for a project which costed Rs 15 crores. New technology was acquired. The Company signed a technology transfer agreement with Indian Veterinary Research Institute for acquiring technology to manufacture PPR and Sheep Pox vaccines in 2011. Company re-launched the bivalent Marek's Disease Live vaccine for the poultry, containing HVT & SB1 strains in 2012-13. It operationalised large animal vaccines division in Mar' 15. During the financial year 2014-15, Gujarat Agrofarm Limited became a wholly owned subsidiary of the Company. During financial year 2015-16, three wholly owned subsidiary Companies namely Gujarat Agrofarm Limited, Diavetra Lifesciences Private Limited and Hester Biosciences (Mauritius) Limited got merged with Company through a Scheme of Arrangement effective on 8 December 2015. Accordingly, the Company allotted and listed its 65 Equity Shares pursuant to Scheme of Arrangement vide order passed by Hon'ble High Court of Gujarat dated 8 December 2015 and the said Shares were listed at NSE Limited and BSE Limited in March, 2016. Leruarua Vetcare (Proprietary) Limited, incorporated in Botswana became an Associate Company with 49% stake of the Company and Innoves Animal Health Private Limited ceases to be an Associate Company due to transfer of shareholding of the Company in FY 2015-16. The Nepal unit completed trial operations and began commercial manufacturing in November, 2016. Leruarua Vetcare (Proprietary) Limited, Botswana ceases to be an Associate Company due to buyback of entire shareholding by the Associate Company during the FY 2016-17. The Company held 65% stake in subsidiary Company, Hester Biosciences Nepal Private Limited (HBNPL) and consequently, HBNPL became a subsidiary of Hester Biosciences Limited (Parent Company) during FY 2016-17. During the year 2017-18, Company acquired 54.80% in the capital of Texas Laboratories, a firm having a business place at Mehsana Distt. of Gujarat. In June 2017, Texas Laboratories converted into Private Limited Company namely, Texas Lifesciences Private Limited. Further, the Company incorporated 100% wholly-owned subsidiary, Hester Biosciences Africa Limited in Tanzania. During the year 2018-19, Hester Biosciences Limited incorporated 100% wholly-owned subsidiary Hester Biosciences Kenya Limited in Kenya.

Hester Biosciences Ltd News Hub

News

Board of Hester Biosciences recommends final dividend

Hester Biosciences announced that the Board of Directors of the Company at its meeting hel...

Read more

10 May 2024 16:16

News

Hester Biosciences to hold board meeting

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 10 May ...

Read more

03 May 2024 10:30

News

Hester Biosciences to declare Quarterly Result

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 2 Febru...

Read more

25 Jan 2024 11:28

News

Hester Biosciences to conduct board meeting

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 7 Novem...

Read more

28 Oct 2023 17:23

News

Hester Biosciences to conduct AGM

Hester Biosciences announced that the 36th Annual General Meeting (AGM) of the company wil...

Read more

24 Aug 2023 12:59

News

Hester Biosciences rises after Q1 PAT jumps 29% YoY to Rs 11 cr

Profit before tax rose 28.95% to Rs 8.73 crore as against Rs 6.77 crore posted in the same...

Read more

08 Aug 2023 16:37

FAQs for dividends of Hester Biosciences Ltd

What is the current market price of Hester Biosciences Ltd Ltd as of May 24, 2024?

The current market price of Hester Biosciences Ltd Ltd stands at 1786.0 per share.

What dividend did Hester Biosciences Ltd declare in the last fiscal year?

In the last fiscal year, Hester Biosciences Ltd declared a dividend totaling ₹6.0.

What is the most recent dividend declared by Hester Biosciences Ltd?

Hester Biosciences Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Hester Biosciences Ltd declared dividends in the current fiscal year

Hester Biosciences Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Hester Biosciences Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Hester Biosciences Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199